Seoul, South Korea

Yun Cheul Kim

This inventor holds 5 USPTO granted patents. Top assignee: Cj Corporation. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun Cheul Kim. Retrieved from https://idiyas.com/inventor/yun-cheul-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 17.2

ph-index = 4

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Yun Cheul Kim

Introduction

Yun Cheul Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 5 patents to his name, Kim continues to push the boundaries of innovation in his industry.

Latest Patents

Among his latest patents, Kim has developed a crystalline organic acid salt of amlodipine. This innovative compound boasts improved physiochemical properties, along with a preparation method and a pharmaceutical composition that incorporates it. Additionally, he has disclosed a novel organic acid salt of amlodipine, detailing its preparation method and a pharmaceutical composition that utilizes it as a therapeutically active ingredient.

Career Highlights

Yun Cheul Kim is currently associated with CJ Corporation, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Kim collaborates with talented colleagues, including Dong Kwon Lim and Hyuk Koo Lee, to further enhance the impact of their research and innovations.

Conclusion

Yun Cheul Kim's contributions to the pharmaceutical industry exemplify the spirit of innovation and dedication to improving health outcomes. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…